R65Q (p.Arg65Gln) variant of KRT1 (Keratin, type II cytoskeletal 1)

R65Q (p.Arg65Gln) in KRT1 (Keratin, type II cytoskeletal 1) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.40 / 1. The record also includes population frequency data and structural context.

R65Q (p.Arg65Gln) variant details